Fig. 1From: The prognostic role of RBP-4 and adiponectin in patients with peripheral arterial disease undergoing lower limb endovascular revascularizationReceiver operating characteristic curve analysis of Retinol-Binding-Protein-4 (RBP4) as prognostic marker of major adverse cardiovascular events (MACE) including acute coronary events and peripheral artery restenosis requiring re-revascularization in patients with peripheral artery disease (PAD) undergoing endovascular revascularizationBack to article page